May 27, 2016
(Bloomberg) – Theranos Inc. was accused in a lawsuit of misleading consumers about the accuracy of its blood test results and reliability of its technology. The suit is the latest setback for the startup since the Wall Street Journal last year raised questions about its test results. The U.S. Securities and Exchange Commission, federal prosecutors in San Francisco, and federal and state health regulators are investigating the company.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.